Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine and ketorolac added to reduced-dose local anesthetic for medial canthus block in vitrectomy surgery
PACTR202204650206424Phase 2Recruiting
- Sponsor
- Research Institute of Ophthalmology
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of neostigmine and ketorolac in None (2 arms), sponsored by Research Institute of Ophthalmology. Started Apr 2022; status: recruiting.
02
Drugs
neostigmineketorolac
Beyond the preview
Go deeper on PACTR202204650206424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202204650206424.